EACS Conference 11-14 November 2009 Cologne
Estimating AIDS and non-AIDS related deaths for patients with missing death data in the EuroSIDA cohort Justyna D. Kowalska, Amanda Mocroft, Bruno Ledergerber, Robert Colebunders, Mattie Ristola, Josip Begovac, Helen Sambatakou, Court Pedersen, Jens D. Lundgren, Ole Kirk
Improvements in mortality between 2002-2007 across Europe : Differences between regions of Europe A Mocroft, B Gazzard, A Karlsson, I Karpov, S D Wit, J v Lunzen, C Katlama, K Zilmer, O Kirk, JD Lundgren on behalf of the EuroSIDA study group.
Tuberculosis (TB) among HIV-1 infected patients across Europe: change over time and risk factors Alexej Kruk, Wendy Bannister, Daria Podlekareva, Nelly Chensova, Aza Rakhmanova, Andrzej Horban, Pere Domingo, Jens D Lundgren, Amanda Mocroft, Ole Kirk, for the EuroSIDA Study Group.
Survival and prognostic factors for patients with non-AIDS defining malignancies (NADM) Csaba Kosa, Joanne Reekie, Johannes Bogner, Pierre-Marie Girard, Gerd Fätkenheuer, Antonio Chiesi, Martin Fisher, Frederik Neess-Engsig, Amanda Mocroft, Ole Kirk
Has the uptake of treatment for chronic hepatitis C virus infection (CHC) in HIV-positive patients in Europe changed over time? A. Mocroft, M. Vogel, M. Beniowski, C. Pradier, M. Battegay, D. Jevtovic, V. Soriano, L. Peters, J. Lundgren,J.K. Rockstroh, for the EuroSIDA Study Group.
Health Care Index (HCI) and Outcome following a diagnosis of tuberculosis (TB) O Kirk, A Mocroft, DN Podlekareva, FA Post, V Riekstina, JM Miro, H Furrer, M Bruyand, AM Panteleev, AG Rakhmanova, E Girardi, MH Losso, JJ Toibaro, J Caylá, RF Miller, N Obel, A Skrahina, N Chentsova, JD Lundgren, and the HIV/TB study group.
Epidemiological and virological characteristics of chronic HBV infection in HIV-positive patients in Europe from 1994 - 2006 Martin Vogel, Amanda Mocroft, Lars Peters, Francisco Antunes, Nikolai Kirkby, Stephane De Wit, Antonella d’Arminio Monforte, Robert Flisiak, Jürgen K. Rockstroh, Vincent Soriano for the EuroSIDA Study Group
Dialysis and renal transplantation in HIV-infected patients: a European survey in 2008 A Mocroft, JC Trullas, F Cofan, J Tourret, A Moreno, C Isnard, C Fux, C Katlama, P Reiss, J Lundgren, JM Gatell, O Kirk, JM Miro and the EuroSIDA Investigators.
Predictors of having a resistance test following confirmed viral load (VL) failure of cART ZV Fox, AN Phillips, A Cozzi-Lepri, A d'Arminio Monforte, A Karlsson, A Mocroft, G Kronborg, J Kjaer, B Clotet and JD Lundgren for the EuroSIDA study group.
Prevalence of HIV-1 drug resistance over calendar time in EuroSIDA patients receiving antiretroviral therapy Wendy Bannister, Alessandro Cozzi-Lepri, Jesper Kjær, Bonaventura Clotet, Adriano Lazzarin, Jean-Paul Viard, Gitte Kronborg, Dan Duiculescu, Marek Beniowski, Ladislav Machala and Andrew Phillips.
5th European Conference on Clinical and Social Research on AIDS and Drugs, Vilnius, April 2009
1. A Regioinal Comparison of the Mode of HIV-1 Transmission n Patients Enrolled in the EuroSIDA Study.J Tverland, J Reekie, M C Paulsen, A Mocroft, A Vassilenko, V Uzdaviniene, N Zakharova, N Chentcova, M Ellefson, O Kirk for EuroSIDA. Poster 72 KB
7th European Drug Resistance Workshop, Stockholm, March 2009
1. Predictors of having a resistance test following at least one episode of viral load (VL) failure of cART: data from EuroSIDA. ZV Fox, AN Phillips, A Cozzi-Lepri, A d'Arminio Monforte, A Karlsson, A Mocroft, G Kronborg, J Kjaer, B Clotet and JD Lundgren for EuroSIDA.
Poster 191 KB
16th Conference on Retroviruses and Opportunistic Infections, Montreal, February 2009
1.High hepatitis C viremia is associated with an increased risk for mortality in HIV/Hepatitis C virus coinfected individuals. J Rockstroh, L Peters, V Soriano, P Reiss, A d'Arminio Monforte, M Beniowski, M Losso, O Kirk, B Kupfer, A Mocroft on behalf of the EuroSIDA Study Group. Oral 111 KB
1.Hyaluronic Acid as a Prognostic Marker of Hepatic Coma and Liver-related Death in HIV/Viral Hepatitis Coinfected Patients. L Peters, A Mocroft, V Soriano, J Rockstroh, B Ledergerber, A Karlsson, B Knysz, C Pradier, K Zimler, JD Lundgren for the EuroSIDA study group.
Poster 139 KB
2.Mutation A376S in the RT connection domain is associated with an increased risk of virological failure to nevirapine- based therapy in NNRTI-naïve HIV-infected subjects in the EuroSIDA Study. R Parades, W Bannister, A Cozzi-Lepri, C Pou, R Bellido, J Bogner, P Gargalianos, D Bánhegyi, B Clotet, JD Lundgren and the EuroSIDA study group.
Poster 247 KB
3.Serious Fatal and Non Fatal Non-AIDS Defining Illnesses (non-ADI) in Europe. A Mocroft, P Reiss, J Gasiorowski, B Ledergerber, A Chiesi, J Gatell, A Rakhmanova, MA Johnson, O Kirk, JD Lundgren for the EuroSIDA study group.
Poster 93 KB